EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Design of Novel Inhibitors: Integrating 3D‐QSAR and Molecular Dynamics

Neda Shakour iD, Aida Fayyaz iD, Farzin Hadizadeh iD, Saghi Sepehri iD

BioMed Research International · 2026

DOI: 10.1155/bmri/4138899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2026. Verfasst von Neda Shakour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dental Research Center, Avicenna Institute of Clinical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran, umsha.ac.ir. Hauptthemen laut MEDLINE: Quantitative Structure-Activity Relationship, Molecular Dynamics Simulation, Urease, Drug Design. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ardabil University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents an integrated computational framework that combines three‐dimensional quantitative structure–activity relationship (3D‐QSAR) modeling with molecular dynamics (MD) simulations to advance the rational design of triazole‐based urease inhibitors. Given the role of urease as a central virulence factor in Helicobacter pylori and its increasing relevance in antibiotic‐resistant infections, effective predictive methodologies are essential for early‐stage inhibitor development. A dataset of 54 triazole derivatives was examined using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA), generating statistically robust and predictive models that elucidate the steric, hydrophobic, and hydrogen‐bonding features underlying inhibitory potency. These insights, supported by molecular docking and structure–activity relationship analyses, informed the construction of a pharmacophore model used to screen the ZINC database. Several candidate molecules, including ZINC84668437, ZINC84669798, and ZINC244633273, emerged as computationally promising and demonstrated favorable predicted druglikeness and ADMET characteristics. MD simulations were subsequently employed to evaluate the dynamic stability and conformational behavior of the ligand–urease complexes, reinforcing the coherence of the integrated computational workflow. The primary contribution of this work resides in its methodological integration of complementary in silico approaches rather than in experimental validation. Although the findings offer mechanistic insights and prioritize potential lead compounds, they remain predictive and necessitate future empirical confirmation. Overall, the study establishes a rigorous and academically grounded computational strategy that can guide subsequent efforts in the design of selective urease inhibitors for H. pylori –associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quantitative Structure-Activity RelationshipMolecular Dynamics SimulationUreaseDrug DesignEnzyme InhibitorsHelicobacter pyloriMolecular Docking SimulationPharmacophoreTriazolesHydrogen BondingLigands

Stichwörter der Autor:innen

3D-QSARADMETHelicobacter pyloridruglikenessmolecular dockingmolecular docking simulationpharmacophore modelingtriazole derivativesurease inhibitorsvirtual screening

Substanzen

UreaseEnzyme InhibitorsTriazolesLigands

Autor:innen und Institutionen

  • Dental Research Center, Avicenna Institute of Clinical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran, umsha.ac.ir.
  • Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran, umsha.ac.ir.
  • Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran, mums.ac.ir.
  • Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran, arums.ac.ir.
  • Students Research Committee, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran, arums.ac.ir.
  • Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, mums.ac.ir.

ORCID-Profile: Neda Shakour, Aida Fayyaz, Farzin Hadizadeh, Saghi Sepehri

Förderung

  • Ardabil University of Medical Sciences

Zitieren

APA

Shakour, N., Fayyaz, A., Hadizadeh, F., & Sepehri, S. (2026). Rational Design of Novel Inhibitors: Integrating 3D‐QSAR and Molecular Dynamics. BioMed Research International. https://doi.org/10.1155/bmri/4138899

Vancouver

Shakour N, Fayyaz A, Hadizadeh F, Sepehri S. Rational Design of Novel Inhibitors: Integrating 3D‐QSAR and Molecular Dynamics. BioMed Research International. 2026. doi:10.1155/bmri/4138899

BibTeX
@article{Shakour2026,
  author = {Shakour, Neda and Fayyaz, Aida and Hadizadeh, Farzin and Sepehri, Saghi},
  title = {Rational Design of Novel Inhibitors: Integrating 3D‐QSAR and Molecular Dynamics},
  journal = {BioMed Research International},
  year = {2026},
  doi = {10.1155/bmri/4138899}
}
Kostenlos starten →